Introduction
In the early 1990s dramatic changes occurred on both the political and economic level in many Central and Eastern European countries. These changes had a major impact on their health care systems including cancer control. The transition was more rapid in certain countries than in others. At the same time, new countries emerged and wartorn regions still exist. It therefore would be difficult to analyse data for the whole area. Instead of such an approach, this review is aimed at reporting on cancer mortality in selected Central and Eastern European countries, as well as summarising the various problems and potential solutions relating to cancer mortality in Hungary.
Statistical data
The source of the comparative cancer mortality data is "Cancer Statistics, 1998," published by the American Cancer Society. In this publication data are compiled on age-adjusted death rates per 100,000 population (AADR/100,000) for major tumour sites in 46 countries worldwide. Death rates are ageadjusted according to the WHO compared to the world standard population. A period from 1992 to 1995 was reviewed and an order of rank within site and sex groups was established [1] . The reliability of the Hungarian mortality data has been locally controlled [2] . Table 1 shows cancer mortality of males in 11 selected Central and Eastern European countries. It is obvious that Hungary and the Czech Republic are leading countries in the list of cancer mortality, ranking 1 st and 2nd, and followed by the Baltic countries, Poland, Slovenia and Croatia. As a group these countries occupy 8 of the 13 highest cancer mortality rates for males among the 46 countries surveyed. It is noteworthy that in the same period the USA was 25th, with 162.7 of 100,000 AADR. The countries in southeastern Europe * AADR = age adjusted death rate **ORWASG = order of rank within all site groups from 46 countries worldwide (Romania, Bulgaria, and Albania) have lower cancer mortality data than those of the central and northern areas. Table 2 summarises cancer mortality of the female population in the 11 selected Central and Eastern European countries. It is evident from these data that Hungary and the Czech Republic have a heavy cancer death toll among females as well (2nd and 3rd place) although Denmark has the highest mortality among the 46 countries. The USA can be found in 9th place with 110.4 of 100,000 AADR. The Baltic countries, Poland, Slovenia and Croatia have somewhat lower mortality figures (range: 111.4-96.4 of 100,000 AADR), and the countries of southeastern Europe are lower still.
In order to identify the factors contributing to these unfortunate cumulative data we analysed the mortality of malignancies according to various tumour major sites. represented by Hungary (84.0 of 100,000 AADR), followed by the Czech Republic, Russia, the Baltic countries, Poland, Slovenia and Croatia. Together, these countries have 9 of the 12 worst lung cancer mortality rates among male populations. In these countries, however, the female population has a much lower lung cancer death rate calculated in absolute numbers except for Hungary which is in 5th place in cancer mortality among the 46 countries. Data on breast cancer mortality are summarised in Table  4 . This table demonstrates that breast cancer mortality is an important factor in the total cancer mortality in females for Hungary, Slovenia and the Czech Republic, while it is not as frequent a cause of death in other Central and Eastern European countries examined. The highest death rates can be found in the Western European countries. The USA figures are lower (15th place) compared to Ireland (1 st place) or Denmark (2nd place).
Figures for prostatic cancer mortality are shown in Table  5 . From these data it is evident that prostatic cancer mortality is not among the foremost important causes of death in the Central and Eastern European countries. Hungary is still in 1st place in the region. However, its AADR value (16.5 of 100,000) is lower than that of the first 3 countries on the list Table 4 Breast cancer mortality in selected Central and Eastern European countries (1992-1995) [1] .
•AADR/100,000
•ORWOSG Colorectal cancer mortality is a major burden in both sexes for Hungary, the Czech Republic and Slovenia (Table 6 ). Hungary and the Czech Republic have the highest rates of mortality from colorectal cancer for both men and women. This malignancy is not a frequent cause of death in several other Central and Eastern European countries selected for analysis. The USA mortality rate is relatively low for this cancer (male: 16.0, female: 10.9 AADR of 100,000).
Values for leukemia mortality are reviewed in Table 7 . Hungary, the Czech Republic and the Baltic countries are leading the list of this type of malignancy and other countries in the region are closely following them. Nevertheless, the scattering of the values is within a relatively narrow range (4.6-5.6 of 100,000) except for Albania. The AADR of 100,000 value for the USA is for 6.4 males and 3.9 females (9th and 12th place).
The figures for oral cavity and pharyngeal carcinoma are extraordinarily high for Hungary as demonstrated in Table 8 . The very high mortality for male oral and pharyngeal cancer in Hungary is a result of a dangerously increasing trend observed in the last two decades. Similar conclusions can be drawn from the data compiled on the female population in which previously this malignancy was virtually non-existent. In all other Central and Eastern European countries the death toll is high for males but much lower for females. In Western Europe, France has the highest AADR/100,000 value for males (12.0, 2nd place). This site of malignancy is less important in the USA (3.4, 32nd place) .
Despite the decreasing rate of stomach cancer mortality, this malignancy is still a major killer in the region.
As demonstrated in Table 9 for gastric cancer AADR/ 100,000 values in the Baltic countries, Slovenia, Hungary, * AADR = age adjusted death rate **ORWOSG = order of rank within organ site groups from 46 countries * AADR = age adjusted death rate **ORWOSG = order of rank within organ site groups from 46 countries * AADR = age adjusted death rate **ORWOSG = order of rank within organ site groups from 46 countries * AADR = age adjusted death rate **ORWOSG = order of rank within organ site groups from 46 countries Croatia and Romania are high in the male population. Although the absolute number of gastric cancer deaths in the female population is lower, a relative excess exists in mortality compared to countries worldwide. By comparison, the USA ranks 46th for males and 39th for females in stomach cancer mortality.
Cancer mortality data for uterine cancer are reviewed in Table 10 . Cervical cancer mortality is the most elevated in Poland and the Baltic countries while Hungary occupies 5th and the Czech Republic the 6th place on the list of order of rank of this malignancy. Other uterine tumours show a similar but variable frequency pattern in the region. The values are low in the USA (AADR/100,000=2.5).
Summarising the most important cancer mortality data one might conclude that for the time being Hungary has the worst situation with regard to the key mortality figures. The AADR for males is the highest among the 46 countries represented and for females is in 2nd place. Similarly, these values are very high for the Czech Republic, followed by Poland, Slovenia and the Baltic countries. This catastrophic situation in Hungary occurred in the last two decades. Table 11 shows the changing tendencies observed according to tumour site in the last 10 years. 
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Except for gastric and cervical cancer there is a steady augmentation in the AADR for all malignancies of major importance. The steepest increase of the values can be found in cancers of the respiratory tract especially in oral and bronchial cancers.
Discussion
Among the various reasons responsible for this tragic situation of cancer mortality in Hungary there are several major factors which must be taken into consideration. They are listed in Tables 12 and 13 .
Important and far-reaching environmental changes occurred in the last three decades in Hungary, while environmental protection remained on a low level. Industrialisation of agriculture, opening of several coal mines, and establishment of a series of chemical plants were major factors which negatively influenced the health status of the population, including cancer mortality. Data show that cancer mortality reached its peak values in highly industrialised regions [3] . Certain genotoxic compounds also could represent a risk for the water supply of exposed individuals [4] . An increase in atmospheric pollution was partly due to insufficient protection against gas output from factories and partly due to the rapid growth in road traffic.
High tobacco consumption represents the greatest carcinogenic risk in Hungary. In 1995 47% of the male and 20.7% of the female population were smokers. The age distribution is shown in Table 14 . Table 12 Major factors responsible for cancer mortality in Hungary (1998).
• Increase in environmental carcinogenic risk factors • Unfavourable lifestyle changes, especially related to high tobacco consumption and dangerous drinking habits • Lack of or insufficient cancer prevention procedures, particularly in screening and early detection The age distribution pattern of cigarette consumption is most unfavourable: the peak value is in the age group of 15-29 [5] . This explains why the very high lung and oral cancer death rate is a problem of priority. Similarly the risk of extensive alcohol consumption is not only a factor responsible for the elevated incidence of oral malignancies but also a promoting factor of liver and upper gastrointestinal tract cancers.
Although a successful cervical screening program has doubled the cure rate of the affected individuals during a period of 20 years, there are still 630 deaths registered yearly showing that the compliance is insufficient [6] . There was no primary mammography screening until 1996 and model screening was introduced only two years ago in a very limited population. Early detection of colorectal and prostatic cancer is not performed in an organised manner. Oral cancer screening does not exist in any form despite earlier modest efforts. Existing screening procedures are summarised in Table 15 .
The reasons for delay in the diagnosis can be partly explained by the lack of cancer awareness among patients themselves. This attitude can be the result of a poor public education. At the same time the scarce availability of imaging facilities might also be responsible for the lag period.
Inadequate therapeutic management might also be a factor contributing to cancer mortality in Hungary. Although there are highly competent physicians and caretakers and the treatment strategy meets international standards, the technical infrastructure is far from satisfactory, particularly with regard to radiotherapy equipment.
Shortage of both medical and paramedical personnel is another problem. At present, 342 physicians are specially trained in oncology, one fourth of the number required to treat cancer patients in an adequate quantitative manner. At the postgraduate level, oncology as an independent curriculum was introduced only five years ago at medical schools. There is much to do in cancer nursing as well since there is a great shortage of well trained individuals.
All these problems have an important common source: unsatisfactory financial support due to a shrinking state budget.
Conclusion
Hungary is making efforts to overcome difficulties encountered in the fight against cancer. A detailed analysis of nationwide data on exogenous carcinogenic risk factors is underway and a coordination of the various risk survey systems is in progress. A review of the lifestyle changes of the Table 15 . Screening and early detection of cancers in Hungary (1998).
National
Limited to Experimental regional models The introduction of screening programs for mammary, colorectal, and oral cancers and further development of cervical cancer screening are planned. Reorganisation of the diagnostic and therapeutic management of cancer patients is taking shape especially in the field of imaging services and radiotherapy. A National Cancer Control Program has been established. With the assistance of various international organisations and institutions (WHO, UICC, World Bank, EORTC, ESMO, ESO) these measures are assuring a gradual amelioration of the present situation. Last but not least, there is a real hope that cancer prevention efforts will be increasingly supported from the state budget.
